Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38287 |
C3a Receptor Agonist
C3a receptor agonist 1,C3a受体激动剂,Complement 3a Receptor Agonist |
Complement System | Immunology/Inflammation |
C3a Receptor Agonist (C3a receptor agonist 1) 结合免疫系统补体途径中的G 蛋白偶联C3a 受体(C3aRs)。在肠缺血再灌注损伤模型中,C3aR 的激活可防止中性粒细胞动员。C3aRs 在成年小鼠的神经祖细胞和未成熟神经元上表达。C3a 在体外刺激神经祖细胞的分化。 | |||
T7497L1 |
C3a 70-77 acetate
C3a 70-77 acetate (63555-63-5 Free base) |
Others | Others |
C3a 70-77 acetate 是对应于 C3a 的 COOH 末端的八肽乙酸酯,具有 C3a 的特异性和 1% 至 2% 的生物活性。 | |||
T7497L |
C3a 70-77 2TFA(63555-63-5(free base))
Complement 3a (70-77) |
Complement System | Immunology/Inflammation |
C3a 70-77 2TFA(63555-63-5(free base)) (Complement 3a (70-77)) 是对应于 C3a 的 COOH 末端的八肽。 | |||
T7497 |
C3a (70-77)
Complement 3a (70-77),C3a 70-77 |
Complement System | Immunology/Inflammation |
C3a (70-77) 是对应于 C3a 的 COOH 末端的八肽。 | |||
TP1193 |
C3a (70-77) TFA (63555-63-5 free base)
C3a (70-77) TFA,Complement 3a (70-77) (TFA) |
||
C3a (70-77) TFA (Complement 3a (70-77) TFA) is a COOH-terminal fragment of the C3a anaphylatoxin peptide. | |||
T75966 |
C3a (70-77) (TFA)
|
||
C3a (70-77) TFA (Complement 3a (70-77) TFA) 为COOH末端对应C3a的八肽,具有C3a的特异性且生物活性约为1至2%。 | |||
T9316 |
JR14a
5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carbonyl)-l-arginine hydrochloride |
Complement System | Immunology/Inflammation |
JR14a (5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carbonyl)-l-arginine hydrochloride) 是补体C3a 受体噻吩拮抗剂,可抑制 C3aR 介导的炎症,对人 C3a 受体的选择性高于 C5a 受体。 | |||
T12851 |
SB290157 trifluoroacetate
|
Complement System | Immunology/Inflammation |
SB290157 trifluoroacetate 是一种选择性 C3a 受体拮抗剂,IC50值为200 nM。 | |||
T37248 |
Pantothenate Kinase Inhibitor
|
||
Pantothenate Kinase Inhibitor (PANKi) is a reversible inhibitor of pantothenate kinase (PanK; IC50s = 70, 92, and 25 nM for PanK1β, PanK2, and PanK3, respectively), the rate-limiting enzyme in the synthesis of coenzyme A .1It binds to the ATP-PanK3 complex with an apparent binding constant of 300 nM and exhibits mixed-type inhibition with respect to ATP and pantothenate. PANKi inhibits CoA biosynthesis in C3A cells (IC50= 0.9 μM) with no effect on cell viability when used at concentrations up to... | |||
T72859 |
11β-HSD1-IN-10
|
||
11β-HSD1-IN-10 (化合物 c3a) 是一种针对11β-HSD1的有效抑制剂,具有对人IC50值为1.8 µM。可应用于肥胖、高血糖和认知障碍研究。 |